Home > Insider Trading > Filing (0001179110-15-009321)

Filing Details

Accession Number:: 0001179110-15-009321
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-06-08 16:36:51
Reporting Period:: 2015-06-05

Filing Date:: 2015-06-08
Accepted Time:: 2015-06-08 16:36:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
792977	Amag Pharmaceuticals Inc.	AMAG	Pharmaceutical Preparations (2834)	042742593

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1214939	K William Heiden	C/O Amag Pharmaceuticals, Inc. 1100 Winter Street Waltham MA 02451	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2015-06-05	6,875	$68.14	208,721	No	4	S	Direct
Common Stock	Acquisiton	2015-06-05	60,000	$12.99	268,721	No	4	M	Direct
Common Stock	Disposition	2015-06-05	6,642	$68.90	262,079	No	4	S	Direct
Common Stock	Disposition	2015-06-05	36,550	$69.77	225,529	No	4	S	Direct
Common Stock	Disposition	2015-06-05	4,680	$70.69	220,849	No	4	S	Direct
Common Stock	Disposition	2015-06-05	12,128	$71.52	208,721	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2015-06-05	60,000	$0.00	60,000	$12.99

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
230,000		2022-05-14	No	4	M	Direct

Footnotes

The reported transactions on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2015.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual prices per share range from $68.14 to $69.13, inclusive. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual prices per share range from $69.15 to $70.00, inclusive. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual prices per share range from $70.18 to $71.15, inclusive. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual prices per share range from $71.20 to $71.25, inclusive. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
This option vests and becomes exercisable in four equal annual installments beginning May 14, 2013.